Dermatology
Optimizing Biologic Therapy for Hidradenitis Suppurativa: Harnessing the End-of-Dose Effect to Improve Patient Outcomes
This study assesses a novel biologic optimization strategy guided by the end-of-dose effect in partial responders with hidradenitis suppurativa, revealing meaningful clinical improvements and offering a framework for personalized treatment
